Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-13

Clinical Trial Update: Chemoablation for Low-Grade Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chemoablation for low-grade bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ekaterina Laukhtina | Conditions: Bladder (Urothelial, Transitional Cell) Cancer | Phase 2 | Status: RECRUITING